These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1986677)
1. The influence of human immunodeficiency virus infection on tuberculosis in Kampala, Uganda. Eriki PP; Okwera A; Aisu T; Morrissey AB; Ellner JJ; Daniel TM Am Rev Respir Dis; 1991 Jan; 143(1):185-7. PubMed ID: 1986677 [TBL] [Abstract][Full Text] [Related]
2. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon. Kuaban C; Bercion R; Koulla-Shiro S East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults. Okwera A; Johnson JL; Vjecha MJ; Wolski K; Whalen CC; Hom D; Huebner R; Mugerwa RD; Ellner JJ Int J Tuberc Lung Dis; 1997 Oct; 1(5):441-5. PubMed ID: 9441099 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of drug resistance in Thai human immunodeficiency virus seropositive tuberculosis patients. Hongthiamthong P; Chuchottaworn C; Amatayakul N J Med Assoc Thai; 1994 Jul; 77(7):363-7. PubMed ID: 7876754 [TBL] [Abstract][Full Text] [Related]
5. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516 [TBL] [Abstract][Full Text] [Related]
6. Stevens-Johnson syndrome during anti-tuberculosis chemotherapy in HIV-seropositive patients: report on six cases. Wirima JJ; Harries AD East Afr Med J; 1991 Jan; 68(1):64-6. PubMed ID: 2060484 [TBL] [Abstract][Full Text] [Related]
7. Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis. Nunn P; Kibuga D; Gathua S; Brindle R; Imalingat A; Wasunna K; Lucas S; Gilks C; Omwega M; Were J Lancet; 1991 Mar; 337(8742):627-30. PubMed ID: 1705647 [TBL] [Abstract][Full Text] [Related]
8. Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda. Joloba ML; Whalen CC; Cave DM; Eisenach KD; Johnson JL; Okwera A; Morrissey A; Bajaksouzian S; Feagin J; Mugerwa R; Ellner J; Jacobs MR East Afr Med J; 2000 Feb; 77(2):111-5. PubMed ID: 10774085 [TBL] [Abstract][Full Text] [Related]
9. Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire. Perriëns JH; Colebunders RL; Karahunga C; Willame JC; Jeugmans J; Kaboto M; Mukadi Y; Pauwels P; Ryder RW; Prignot J Am Rev Respir Dis; 1991 Oct; 144(4):750-5. PubMed ID: 1928943 [TBL] [Abstract][Full Text] [Related]
10. [A clinical research on human immunodeficiency virus seropositive patients with pulmonary tuberculosis]. Wang W; Cram AR; Micah ST Zhonghua Jie He He Hu Xi Za Zhi; 2000 Nov; 23(11):663-5. PubMed ID: 11225029 [TBL] [Abstract][Full Text] [Related]
11. Life-threatening cutaneous reactions to thiacetazone-containing antituberculosis treatment in Kumasi, Ghana. Lawn SD; Frimpong EH; Acheampong JW West Afr J Med; 1999; 18(4):249-53. PubMed ID: 10734785 [TBL] [Abstract][Full Text] [Related]
12. Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection. Chaisson RE; Clermont HC; Holt EA; Cantave M; Johnson MP; Atkinson J; Davis H; Boulos R; Quinn TC; Halsey NA Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1034-8. PubMed ID: 8887603 [TBL] [Abstract][Full Text] [Related]
13. Current HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone-free antituberculosis treatment in Yaounde, Cameroon. Kuaban C; Bercion R; Koula-Shiro S Cent Afr J Med; 1998 Feb; 44(2):34-7. PubMed ID: 9675969 [TBL] [Abstract][Full Text] [Related]
14. Impact of human immunodeficiency virus type 1 on tuberculosis in rural Haiti. Long R; Scalcini M; Manfreda J; Carré G; Philippe E; Hershfield E; Sekla L; Stackiw W Am Rev Respir Dis; 1991 Jan; 143(1):69-73. PubMed ID: 1898847 [TBL] [Abstract][Full Text] [Related]
15. [HIV infections and tuberculosis in Haiti]. Hyppolite PR; Pape JW Bol Oficina Sanit Panam; 1995 Feb; 118(2):161-9. PubMed ID: 7695820 [No Abstract] [Full Text] [Related]
16. [Treatment of patients with pulmonary tuberculosis in the city of Kampala (Uganda)]. Boboreko ET Probl Tuberk; 1970; 48(9):62-5. PubMed ID: 5518276 [No Abstract] [Full Text] [Related]
17. Clinical pattern of human immunodeficiency virus infection (HIV) in pulmonary tuberculosis patients in Jos, Nigeria. Anteyi EA; Idoko JA; Ukoli CO; Bello CS Afr J Med Med Sci; 1996 Dec; 25(4):317-21. PubMed ID: 9532299 [TBL] [Abstract][Full Text] [Related]
18. Tuberculous lymphadenitis associated with human immunodeficiency virus (HIV) in Uganda. Nambuya A; Sewankambo N; Mugerwa J; Goodgame R; Lucas S J Clin Pathol; 1988 Jan; 41(1):93-6. PubMed ID: 3343383 [TBL] [Abstract][Full Text] [Related]
19. [Pulmonary tuberculosis: differences between patients seropositive and seronegative for the acquired immunodeficiency virus]. Fernández Revuelta A; Arazo Garcés P; Aguirre Errasti JM; Arribas Llorente JL An Med Interna; 1993 Aug; 10(8):381-5. PubMed ID: 8218782 [TBL] [Abstract][Full Text] [Related]
20. Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania. Dukes CS; Sugarman J; Cegielski JP; Lallinger GJ; Mwakyusa DH Trop Geogr Med; 1992 Oct; 44(4):308-11. PubMed ID: 1284179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]